e Internet. Ito has been investing professionally since 2000 when he established Neoteny, an investment firm in Tokyo. Ito is chair of the board of PureTech Health, an advanced, clinical-stage biopharmaceutical company listed on the London Stock Exchange. He serves on the board of The New York Times Company. He